Teva Gains Another $2.48 Billion For Selling The Last Of Its Women???s Health Portfolio Post author:Sam Post published:September 17, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like What You Need to Know About Shepherd Therapeutics January 16, 2018 Tiny Zymeworks Snags $1.4B+ R&D Deal With Drug Giant Johnson & Johnson November 12, 2017 The Medicines Company To Present Data At On Infectious Disease Portfolio Including Recently Approved Antibiotic VABOMERE(Meropenem And Vaborbactam) September 28, 2017
The Medicines Company To Present Data At On Infectious Disease Portfolio Including Recently Approved Antibiotic VABOMERE(Meropenem And Vaborbactam) September 28, 2017